Cipla's Goa plant classified as 'Official Action Indicated' by USFDA; stock falls
USFDA may continue to withhold product approvals from this facility till the outstanding observations are resolved, says Cipla.
cipla
November 2022
September 2022
December 2021
November 2021
June 2021
April 2021
January 2021
November 2020
Surprise! Despite Covid-19 sales, Indian pharma an underperformer
A majority of pharma stocks reported double digit negative returns, while the overall market (BSE Sensex) delivered a 9% plus return.
Oral pills for Covid-19 by Sun Pharma, Cipla, Torrent & Strides
Sun Pharma will sell Molnupiravir under the brand name Molxvir in India, Torrent Pharma will sell it as Molnutor, while Cipla will market it as Cipmolnu.
Competitors Within
Home-grown smaller players are giving biggies a run for their money in the US generics market.
Get ready to surf India’s health tech wave
A great pharma and medical supply chain, large population, intent among health professionals to innovate, and willingness among customers to try new solutions will ensure the sector's success.
Making India breathe free beyond Covid-19
The pandemic is a timely and apt reminder to pay heed to our respiratory health, and particularly the lungs.
Reimagining Indian pharma
India’s pharma industry is reimagining itself. This is not just borne out of the necessities brought forth by the pandemic, but is a blueprint to thrive and to succeed in this new world.
The new year playbook: India Inc. predicts 2021
2020 was a transformative year, with Covid-19 altering the corporate landscape like never before. But now that 2021 is here, how different will it turn out to be? Ten leaders of India Inc. weigh in.
Hope and prayer: Race for the Covid-19 vaccine
As the world awaits a panacea for Covid-19, pharma companies have their feet firmly on the accelerator to get people a safe vaccine to stem the spiral of death and illness looming over humanity.
Healthcare leaders shine in MPW 2020 list
Cipla’s Samina Hamied, Lupin’s Vinita Gupta biggest rank gainers from the sector.
